UnknownNot Applicable

An Observational Study of Ertapenem in Outpatient Parenteral Antibiotic Therapy (OPAT) for Complicated Urinary Tract Infections.

Singapore60 participantsStarted 2010-08

Plain-language summary

The aim of this study is to determine the outcomes when using ertapenem for complicated urinary tract infections in the OPAt setting. The study hypothesis: Ertapenem is an efficacious and safe therapeutic option for complicated urinary tract infections in the OPAt setting.

Who can participate

Age range21 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult patients between 21 years old to 70 years old. * Diagnosed with complicated urinary tract infection due to pathogen susceptible to ertapenem based on microbiology report, and the use of ertapenem is deemed clinically appropriate by the Infectious Disease physician in charge. Exclusion Criteria: * Hypersensitivity reactions to Ertapenem. * Participation in another interventional clinical investigation within 30days * Unable to obtain informed consent.

What they're measuring

Clinical Outcome

Timeframe: within 14 days of treatment and within 1 months after the treatment completion.

Trial details

NCT IDNCT01173068

SponsorNational University Hospital, Singapore

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2014-09

Contact for this trial

Dale A Fisher

(65) 6772 43 73 dale_andrew_fisher@nuhs.edu.sg

View on ClinicalTrials.gov More Urinary Tract Infections trials